Bluejay Diagnostics (BJDX) Enterprise Value (2020 - 2026)

Bluejay Diagnostics has disclosed Enterprise Value across 7 years of filings, most recently posting -$3.7 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$3.7 million, down 18.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 18.24% YoY), and the FY2025 annual result was -$5.2 million, down 20.06% from the prior year.
• Enterprise Value came in at -$3.7 million for Q1 2026 at Bluejay Diagnostics, up from -$5.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$2.2 million in Q4 2023 to a low of -$17.1 million in Q1 2022.
• The 5-year median for Enterprise Value is -$5.1 million (2023), against an average of -$6.8 million.
• Across the five-year window, Enterprise Value slumped 470.33% in 2022 and surged 78.17% in 2023, its largest moves.
• Bluejay Diagnostics' Enterprise Value stood at -$10.1 million in 2022, then soared by 78.17% to -$2.2 million in 2023, then sank by 94.79% to -$4.3 million in 2024, then fell by 20.06% to -$5.2 million in 2025, then advanced by 28.66% to -$3.7 million in 2026.
• The last three Enterprise Value figures came in at -$3.7 million (Q1 2026), -$5.2 million (Q4 2025), and -$3.1 million (Q3 2025), per Business Quant data.